Literature DB >> 28821625

Vaccine Education During Pregnancy and Timeliness of Infant Immunization.

Priya Veerasingam1, Cameron C Grant2,3,4,5, Carol Chelimo3,4,5, Kathryn Philipson5, Catherine A Gilchrist5, Sarah Berry3,4, Polly Atatoa Carr3,4, Carlos A Camargo6, Susan Morton3,4.   

Abstract

OBJECTIVES: Pregnant women routinely receive information in support of or opposing infant immunization. We aimed to describe immunization information sources of future mothers' and determine if receiving immunization information is associated with infant immunization timeliness.
METHODS: We analyzed data from a child cohort born 2009-2010 in New Zealand. Pregnant women (N = 6822) at a median gestation of 39 weeks described sources of information encouraging or discouraging infant immunization. Immunizations received by cohort infants were determined through linkage with the National Immunization Register (n = 6682 of 6853 [98%]). Independent associations of immunization information received with immunization timeliness were described by using adjusted odds ratios (ORs) and 95% confidence intervals (CIs).
RESULTS: Immunization information sources were described by 6182 of 6822 (91%) women. Of these, 2416 (39%) received information encouraging immunization, 846 (14%) received discouraging information, and 565 (9%) received both encouraging and discouraging information. Compared with infants of women who received no immunization information (71% immunized on-time), infants of women who received discouraging information only (57% immunized on time, OR = 0.49, 95% CI 0.38-0.64) or encouraging and discouraging information (61% immunized on time, OR = 0.51, 95% CI 0.42-0.63) were at decreased odds of receiving all immunizations on time. Receipt of encouraging information only was not associated with infant immunization timeliness (73% immunized on time, OR = 1.00, 95% CI 0.87-1.15).
CONCLUSIONS: Receipt, during pregnancy, of information against immunization was associated with delayed infant immunization regardless of receipt of information supporting immunization. In contrast, receipt of encouraging information is not associated with infant immunization timeliness.
Copyright © 2017 by the American Academy of Pediatrics.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28821625     DOI: 10.1542/peds.2016-3727

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  6 in total

1.  Refusal of Vitamin K by Parents of Newborns: A Qualitative Study.

Authors:  Jaspreet Loyal; Theresa R Weiss; Jessica H Cheng; Laura R Kair; Eve Colson
Journal:  Acad Pediatr       Date:  2019-04-11       Impact factor: 3.107

2.  Vaccination information fathers receive during pregnancy and determinants of infant vaccination timeliness.

Authors:  Catherine A Gilchrist; Carol Chelimo; Ryan Tatnell; Polly Atatoa Carr; Carlos A Camargo; Susan Morton; Cameron C Grant
Journal:  Hum Vaccin Immunother       Date:  2021-11-19       Impact factor: 3.452

3.  Routine Pediatric Vaccination During Pandemic: Attitudes of Parents.

Authors:  Sibel Baktır Altuntaş; Gizem Kara Elitok
Journal:  Turk Arch Pediatr       Date:  2022-05

4.  Missed hepatitis B birth dose vaccine is a risk factor for incomplete vaccination at 18 and 24 months.

Authors:  Peyton Wilson; Genevieve Taylor; Jamie Knowles; Elizabeth Blyth; Jeff Laux; Jacob Lohr; Ravi Jhaveri
Journal:  J Infect       Date:  2018-10-04       Impact factor: 6.072

5.  Attitudes toward vaccinations are becoming more polarized in New Zealand: Findings from a longitudinal survey.

Authors:  Carol H J Lee; Chris G Sibley
Journal:  EClinicalMedicine       Date:  2020-06-06

6.  EPI immunization coverage, timeliness and dropout rate among children in a West Cameroon health district: a cross sectional study.

Authors:  Jérôme Ateudjieu; Martin Ndinakie Yakum; André Pascal Goura; Ayok Maureen Tembei; Douanla Koutio Ingrid; Beyala Bita'a Landry; Bruno Kenfack; Lapia Amada; Isaac Tadzong; Anne Cecile Bissek
Journal:  BMC Public Health       Date:  2020-02-13       Impact factor: 3.295

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.